首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of clinical pharmacy and therapeutics

缩写:J CLIN PHARM THER

ISSN:0269-4727

e-ISSN:1365-2710

IF/分区:1.1/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引2121
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sarfaraz K Niazi Sarfaraz K Niazi
What is known and objective: The United States is the only country with legislation to approve two classes of biosimilars. One has "no clinically meaningful difference" from the reference product, and when it is tested fo...
Sarah Seiberth,Hanna Mannell,Christof Birkenmaier et al. Sarah Seiberth et al.
What is known and objective: A 'renal pharmacist consultant service' (RPCS) reviewing patients' charts with renal impairment (RI) for drug-related problems (DRP) can foster patient safety. However, the benefit of this ser...
Hui Cao,Wei Wei,Yang Lu Hui Cao
What is known and objective: Camrelizumab, a humanized monoclonal programmed cell death protein-1 antibody independently developed by China, is introduced as a treatment selection for non-small cell lung cancer (NSCLC). T...
Phung Thanh Huong,Tran Ngan Ha,Tran Thi Quynh Nhu et al. Phung Thanh Huong et al.
What is known and objective: Allopurinol, the first-line medication for hyperuricemia is well-known for its association with severe cutaneous adverse reactions, especially Stevens-Johnson syndrome (SJS) and toxic epiderma...
Agostina Secchi,Andrew Booth,Ian Maidment et al. Agostina Secchi et al.
What is new and objectives: Older people from ethnic minorities experience the intersectionality of age and ethnicity in relation to complex medication management and polypharmacy. Minority ethnic groups in the United Kin...
Mehmet Eyuboglu,Atac Celik Mehmet Eyuboglu
What is known and objective: Empagliflozin treatment is significantly associated with lower risk of cardiovascular events in patients with diabetes mellitus (DM) independent of its antihyperglycemic effect. However, littl...
Lina Shao,Chuxuan Luo,Chaoyun Yuan et al. Lina Shao et al.
What is known and objective: Patients with kidney disease receiving immunosuppressive drugs (ISDs) (tacrolimus, cyclosporine and glucocorticoids) have a high risk of developing new-onset diabetes mellitus (NODM). We aimed...
Tao Ling,Lianghui Zhang,Lingli Huang Tao Ling
What is known and objective: This study was performed to compare the efficacy and safety of combined administration of intravenous (IV) and intra-articular (IA) tranexamic acid (TXA) with IV or IA TXA alone in total knee ...
Jingchao Yan,Xiaomei Xiong,Jianwen Shen et al. Jingchao Yan et al.
What is known and objective: Adverse drug reaction (ADR) reporting is generally of poor quality, which may delay post-marketing regulatory actions. Here, we evaluated the quality of ADR reporting at our institution and ex...